Test for quinolone resistance in typhoid fever

Comment

Christopher M Parry et al. BMJ. 2006.

. 2006 Jul 29;333(7561):260-1.

doi: 10.1136/bmj.333.7561.260-b.

No abstract available

Comment in

Fluoroquinolone resistance in Salmonella Typhi.
Cooke FJ, Wain J, Threlfall EJ. Cooke FJ, et al. BMJ. 2006 Aug 12;333(7563):353-4. doi: 10.1136/bmj.333.7563.353-b. BMJ. 2006. PMID: 16902221 Free PMC article. No abstract available.

Current concepts in the diagnosis and treatment of typhoid fever.
Bhutta ZA. Bhutta ZA. BMJ. 2006 Jul 8;333(7558):78-82. doi: 10.1136/bmj.333.7558.78. BMJ. 2006. PMID: 16825230 Free PMC article. Review. No abstract available.

1. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006;333: 78-82. (7 July.) - PMC - PubMed
1. British Society for Antimicrobial Chemotherapy. BSAC methods for antimicrobial susceptibility testing. Version 6. Birmingham: BSAC, 2006.www.bsac.org.uk/_db/_documents/version_5_.pdf (accessed 10 Jun 2006).
1. Rupali P, Abraham OC, Jesudason MV, John TJ, Zachariah A, Sivaram S, Mathai D. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 2004;49: 1-3. - PubMed
1. Parry CM. The treatment of multidrug resistant and nalidixic acid resistant typhoid fever in Vietnam. Trans Roy Soc Trop Med Hyg 2004;98: 413-22. - PubMed
1. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne, PA: CLSI, 2006. (16th informational supplement, M100-S16.)